Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5061-5066

  Bertagnoli, Stephane ^a   Gelfi, Jacqueline ^a   Le Gall, Ghislaine ^b   Boilletot, Eric ^b   Vautherot, Jean Francois ^c   Rasschaert, Denis ^c   Laurent, Sylvie ^c   Petit, Frederique ^a   Boucraut Baralon, Corine ^a   Milon, Alain ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b Healthy Pigs Production and Experimentation Section   (France)

^c INRA Institut National de la Recherche Agronomique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; THYMIDINE KINASE; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL MODEL; ANTIBODY TITER; ANTIGENICITY; ARTICLE; BLEEDING; CONTROLLED STUDY; DNA VIRUS; GENE EXPRESSION; IMMUNE RESPONSE; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; RABBIT; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS VIRULENCE;

EID: 8944231650     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5061-5066.1996     Document Type: Article

References (37)

1. Argüello Villares, J. L. 1991. Viral haemorrhagic disease of rabbits: vaccination and immune response. Rev. sci. Tech. Off. Int. Epiz. 10:471-480.
2. Bertagnoli, S., J. Gelfi, F. Petit, J. F. Vautherot, D. Rasschaert, S. Laurent, G. Le Gall, E. Boilletot, J. Chantal, and C. Boucraut-Baralon. Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus. Vaccine, in press.
3. Blancou, J., M. P. Kieny, R. Lathe, J.-P. Lecocq, P.-P. Pastoret, J. P. Soulebot, and J. P. Desmettre. 1986. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature (London) 322:373-375.
4. Boga, J. A., R. Casais, M. S. Marin, J. M. Martin-Alonso, R. S. Carmenes, M. Prieto, and F. Para. 1994. Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89). J. Gen. Virol. 75:2409-2413.
5. Boucraut-Baralon, C., F. Petit, R. Py, S. Bertagnoli, and J. Chantal. 1994. Epidémiologic moléculaire du virus de la myxomatose par électrophorése en champs pulsés, p. 1-8. In INRA-ITVAI, Vléme Journées de la Recherche Cunicole, La Rochelle, France, 6 and 7 December 1994.
6. Brochier, B., M. P. Kieny, F. Costy, P. Coffens, B. Bauduin, J.-P. Lecocq, B. Languet, G. Chappuis, J. P. Desmettre, K. Afiademomyo, R. Libois, and P.-P. Pastoret. 1991. Large-scale cradication of rabies using recombinant vaccinia-rabies vaccine. Nature (London) 354:520-522.
7. Brun, A., A. Godard, and Y. Moreau. 1981. La vaccination contre la myxomatose, vaccins hétérologues et homologues. Bull. Soc. Sci. Vet. Med. Comp. 83:251-254. (In French.)
8. Buller, R. M. L., G. L. Smith, K. Cremer, A. L. Notkins, and B. Moss. 1985. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (London) 317:813-815.
9. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
10. Drillien, R., D. Spehner, A. Kirn, P. Giraudon, R. Buckland, F. Wild, and J.-P. Lecocq. 1988. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein. Proc. Natl. Acad. Sci. USA 85:1252-1256.
11. Fenner, F., and F. N. Ratcliffe. 1965. Myxomatosis. Cambridge University Press, London.
12. Francki, R. I. B., C. M. Fauquet, D. L. Knudson, and F. Brown (ed.). 1991. Classification and nomenclature of viruses. Fifth Report of the International Committee on Taxonomy of Viruses. Arch. Virol. 1991(Suppl. 2):1-450.
13. Giavedoni, L., L. Jones, C. Mebus, and T. Yilma. 1991. A vaccinia virus double recombinant expressing F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions. Proc. Natl. Acad. Sci. USA 88:8011-8015.
14. Graham, K. A., A. Opgenorth, C. Upton, and G. McFadden. 1992. Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virology 191:112-124.
15. Jackson, R. J., and H. G. Bults. 1992. The myxoma virus thymidine kinase gene: sequence and transcriptional mapping. J. Gen. Virol. 73:323-328.
16. Jones, L., L. Giavedoni, J. T. Saliki, C. Brown, C. Mebus, and T. Yilma. 1993. Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and the H genes of rinderpest virus. Vaccine 11:961-964.
17. Kieny, M. P., R. Lathe, R. Drillien, D. Spehner, S. Skory, D. Schmitt, T. Wiktor, H. Koprowski, and J. P. Lecocq. 1984. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature (London) 312:163-166.
18. Laurent, S., J.-F. Vautherot, M.-F. Madelaine, G. Le Gall, and D. Rasschaert. 1994. Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into virus-like particles and induces protection. J. Virol. 68:6794-6798.
19. Liu, S. J., H. P. Xue, B. Q. Pu, and S. H. Qian. 1984. A new viral disease in rabbits. Anim. Husb. Vet. Med. 16:253-255. (In Chinese.)
20. Marcato, P. S., C. Benazzi, G. Vecchi, M. Galeotti, L. Della Salda, G. Sarti, and P. Lucidi. 1991. Clinical and pathological features of viral haemorrhagic disease of rabbits and of the European brown hare syndrome. Rev. Sci. Tech. Off. Int. Epiz. 10:371-392.
21. Meyers, G., C. Wirblich, and H. J. Thiel. 1991. Rabbit hemorrhagic disease virus - molecular cloning and nucleotide sequencing of a calicivirus genome. Virology 184:664-676.
22. Morisse, J.-P., G. Le Gall, and E. Boilletot. 1991. Hepatitis of viral origin in Leporidae: introduction and aetiological hypotheses. Rev. Sci. Tech. Off. Int. Epiz. 10:283-295.
23. Moss, B., G. L. Smith, J. L. Gerin, and R. H. Purcell. 1984. Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (London) 311:67-69.
24. Nagy, E., P. J. Krell, R. A. Heckert, and J. B. Derbyshire. 1993. Vaccination of chickens with the hemagglutinin-neuraminidase gene of newcastle disease virus under the control of the fowlpox virus thymidine kinase promoter. Can. J. Vet. Res. 57:306-308.
25. Ohlinger, V. F., B. Haas, G. Meyers, F. Weiland, and H. J. Thiel. 1990. Identification and characterization of the virus causing rabbit hemorrhagic disease J. Virol. 64:3331-3336.
26. Opgenorth, A., K. A. Graham, N. Nation, D. Strayer, and G. McFadden. 1992. Deletion analysis of two tandemly arranged virulence genes in myxoma virus M11L and myxoma growth factor. J. Virol. 66:4720-4731.
27. Panicali, D., and E. Paoletti. 1982. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc. Natl. Acad. Sci. USA 79: 4927-4931.
28. Parra, F., and M. Prieto. 1990. Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits. J. Virol. 64:4013-4015.
29. Petit, F., C. Boucraut-Baralon, R. Py, and S. Bertagnoli. Analysis of myxoma virus genome using pulsed field gel electrophoresis. Vet. Microbiol., in press.
30. Rasschaert, D., S. Huguet, M. F. Madelaine, and J. F. Vautherot. 1995. Sequence and genomic organization of a rabbit haemorrhagic disease virus isolated from a wild rabbit. Virus Genes 9:121-132.
31. Rodak, L., B. Smid, L. Valicek, T. Vesely, J. Stepanek, J. Hampl, and E. Jurak. 1990. Enzyme-linked immunosorbent assay of antibodies to rabbit haemorrhagic disease virus and determination of its major structural proteins. J. Gen. Virol. 71:1075-1080.
32. Romero, C. H., T. Barrett, S. A. Evans, R. P. Kitching, P. D. Gershon, C. Bostock, and D. N. Black. 1993. Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 11:737-742.
33. Russell, R. J., and S. J. Robbins. 1989. Cloning and molecular characterization of the myxoma virus genome. Virology 170:147-159.
34. Saurat, P., Y. Gilbert, and J.-P. Ganière. 1978. Etude d'une souche de virus myxomateux modifié. Rev. Med. Vet. 129:415-451. (In French.)
35. Smith, G. L., B. R. Murphy, and B. Moss. 1983. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc. Natl. Acad. Sci. USA 80:7155-7159.
36. Upton, C., J. L. Macen, and G. McFadden. 1987. Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha. J. Virol. 61:1271-1275.
37. Wiktor, T. J., R. I. Macfarlan, K. Reagan, B. Dietzschold, P. Curtis, W. H. Wunner, M. P. Kieny, R. Lathe, J.-P. Lecocq, M. Macket, B. Moss, and H. Koprowski. 1984. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 81:7194-7198.